Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
Main Authors: | Kageaki Watanabe, MD, Rui Kitadai, MD, Shingo Kitagawa, MD, Takashi Toya, MD, Yukio Hosomi, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | JTO Clinical and Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364320300515 |
Similar Items
-
Pure Red Cell Aplasia Following Interleukin-2 Therapy
by: Janice P. Dutcher MD, et al.
Published: (2016-04-01) -
Skin puckering and edema during durvalumab therapy
by: Brianna Olamiju, BA, et al.
Published: (2021-01-01) -
Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide
by: Tomoki Ito, et al.
Published: (2018-01-01) -
Pure Red Cell Aplasia Associated with Good Syndrome
by: Masayuki Okui, et al.
Published: (2017-04-01) -
Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
by: Alexandre Gérard, et al.
Published: (2020-08-01)